From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
“The idea of having a trusted partner was so important to us leading up to launch.”
Senior Vice President | Finance
We know how much weighs on the minds of pre-commercial pharmaceutical manufacturers. Clinical trials, government agency meetings, regulatory approval, and achieving that elusive PDUFA data and approval. Even once you’re ready to define your commercialization strategy and prepare for launch, there’s all of the necessary planning lead time as well as numerous obstacles.
Insight into competitive market baskets trends around rebating, distribution, contracting, and patient support strategies
Understanding the role and economic position of payers, distributors, PBMs, and other ecosystem players
Building a credible, consensus forecast without historical data or industry benchmarks
Concern over how to ensure compliance given the every-changing regulatory landscape and policies
Creating a right-sized, data-driven process for tracking product launch success
Creating a trusted, audit-ready net-pricing model without deep, in-house gross-to-net experts
Launch Readiness Timeline
Successful pharmaceutical manufacturers create a sound drug launch strategy by choosing a partner that can outline and evolve strategy to market access execution, while maintaining agility to pivot along the path to commercialization. IntegriChain specializes in first-time drug launches and helps ensure an orderly preparation across critical business functions. Our ICyte platform combined with our advisory and strategy consulting services help solve these launch readiness challenges.
200 + product launch experts, supported by market-tested, archetype-based launch roadmaps
Comprehensive market benchmark data to measure the effectiveness of payer mix and channel strategy
Proven Commercial, Government, and Compliance, and Gross-to-Net Roadmap to Launch blueprints
Agile, flexible engagement coupled with “white-glove” care, and deep regulatory insights and expertise
Unified data, with pre-built connectors, offers a single source of truth
Business Process-as-a-Service (BPaaS) teams, with 200 + members, work as an adjunct to your commercialization teams
Measure Operational Performance Day 1 with actionable data
Audit-ready, market-proven gross-to-net systems and processes provide insight into net-price and daily operational performance
Drug Commercialization 101.
Based on our experience with more than 100 Chief Commercial Officers and CEOs, here are 10 ways to pressure-test the readiness of your commercialization strategies
COMMERCIALIZATION CHECKLIST
We asked three market access leaders with significant launch experience across multiple therapeutic categories from companies planning to launch or have launched their first product several questions about their launch journey.
Read the post
